These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6864917)

  • 61. Genotypes of N-acetyltransferase-2 and risk of bladder cancer: a case-control study.
    Filiadis IF; Georgiou I; Alamanos Y; Kranas V; Giannakopoulos X; Lolis D
    J Urol; 1999 May; 161(5):1672-5. PubMed ID: 10210437
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
    Kim IY; Lee DH; Lee DK; Kim WJ; Kim MM; Morton RA; Lerner SP; Kim SJ
    Cancer Res; 2004 Oct; 64(20):7355-60. PubMed ID: 15492256
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alteration of the vascular endothelial growth factor and angiopoietins-1 and -2 pathways in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Schlott T; Korabiowska M; Käthei N; Zöller G; Glaser F; Kunze E
    Anticancer Res; 2004; 24(5A):2745-56. PubMed ID: 15517881
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The growth inhibitory effect of p21 adenovirus on human bladder cancer cells.
    Hall MC; Li Y; Pong RC; Ely B; Sagalowsky AI; Hsieh JT
    J Urol; 2000 Mar; 163(3):1033-8. PubMed ID: 10688044
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correlation between messenger RNA expression and protein expression of immune checkpoint-associated molecules in bladder urothelial carcinoma: A retrospective study.
    Le Goux C; Damotte D; Vacher S; Sibony M; Delongchamps NB; Schnitzler A; Terris B; Zerbib M; Bieche I; Pignot G
    Urol Oncol; 2017 May; 35(5):257-263. PubMed ID: 28291636
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Apoptosis and expression of PCNA in superficial transitional cell bladder cancer as related to recurrence].
    Chen L; Wang X; Mei H; Chen W
    Zhonghua Wai Ke Za Zhi; 1998 Aug; 36(8):484-6. PubMed ID: 11825447
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Genome-wide screening and identification of long noncoding RNAs and their interaction with protein coding RNAs in bladder urothelial cell carcinoma.
    Wang L; Fu D; Qiu Y; Xing X; Xu F; Han C; Xu X; Wei Z; Zhang Z; Ge J; Cheng W; Xie HL
    Cancer Lett; 2014 Jul; 349(1):77-86. PubMed ID: 24705305
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.
    Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
    Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Familial aggregation of urothelial carcinoma.
    Mahboubi AO; Ahlvin RC; Mahboubi EO
    J Urol; 1981 Nov; 126(5):691-2. PubMed ID: 7053069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The NOTCH pathway plays a tumor suppressive role in bladder cancer.
    Cancer Discov; 2014 Nov; 4(11):1252. PubMed ID: 25367939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mutations of RAS gene family in specimens of bladder cancer.
    Karimianpour N; Mousavi-Shafaei P; Ziaee AA; Akbari MT; Pourmand G; Abedi A; Ahmadi A; Afshin Alavi H
    Urol J; 2008; 5(4):237-42. PubMed ID: 19101897
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Deletions of p15 and p16 in schistosomal bladder cancer correlate with transforming growth factor-alpha expression.
    Swellam M; El-Aal AA; AbuGabel KM
    Clin Biochem; 2004 Dec; 37(12):1098-104. PubMed ID: 15589816
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clonal analysis of human recurrent superficial bladder cancer by immunohistochemistry of P53 and retinoblastoma proteins.
    Chern HD; Becich MJ; Persad RA; Romkes M; Smith P; Collins C; Li YH; Branch RA
    J Urol; 1996 Nov; 156(5):1846-9. PubMed ID: 8863629
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
    Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
    Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
    [TBL] [Abstract][Full Text] [Related]  

  • 75. NAT2 slow acetylation and bladder cancer in workers exposed to benzidine.
    Carreón T; Ruder AM; Schulte PA; Hayes RB; Rothman N; Waters M; Grant DJ; Boissy R; Bell DA; Kadlubar FF; Hemstreet GP; Yin S; LeMasters GK
    Int J Cancer; 2006 Jan; 118(1):161-8. PubMed ID: 16003747
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Association of microalbuminuria with slow acetylator phenotype in type 1 diabetes mellitus.
    Madácsy L; Szórády I; Sánta A; Barkai L; Vámosi I
    Child Nephrol Urol; 1992; 12(4):192-6. PubMed ID: 1473091
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Altered RECQL5 expression in urothelial bladder carcinoma increases cellular proliferation and makes RECQL5 helicase activity a novel target for chemotherapy.
    Patterson K; Arya L; Bottomley S; Morgan S; Cox A; Catto J; Bryant HE
    Oncotarget; 2016 Nov; 7(46):76140-76150. PubMed ID: 27764811
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Urinary bladder cancer in a girl with a slow-acetylator genotype and treated with sulphasalazine.
    Espin Jaime MT; Moran Penco JM; Garcia Agundez JA; Caballero Loscos MJ; Sanjuan Rodriguez S; Botello Martinez F; Gomez de Tbjada R; Laguna Alvarez E; Benitez Rodriguez I
    Br J Urol; 1997 Jul; 80(1):151-2. PubMed ID: 9240200
    [No Abstract]   [Full Text] [Related]  

  • 79. Anergy and tryptophan metabolism in bladder cancer.
    Romas NA; Ionascu L; Ionescu G; Wechsler M; Tannenbaum M; Veenema RJ
    J Urol; 1976 Apr; 115(4):387-9. PubMed ID: 1263311
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Familial and genetic risk of transitional cell carcinoma of the urinary tract.
    Mueller CM; Caporaso N; Greene MH
    Urol Oncol; 2008; 26(5):451-64. PubMed ID: 18562223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.